These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Standardized Index of Shape (DCE-MRI) and Standardized Uptake Value (PET/CT): Two quantitative approaches to discriminate chemo-radiotherapy locally advanced rectal cancer responders under a functional profile. Petrillo A, Fusco R, Petrillo M, Granata V, Delrio P, Bianco F, Pecori B, Botti G, Tatangelo F, Caracò C, Aloj L, Avallone A, Lastoria S. Oncotarget; 2017 Jan 31; 8(5):8143-8153. PubMed ID: 28042958 [Abstract] [Full Text] [Related]
3. The predictive role of sequential FDG-PET/CT in response of locally advanced rectal cancer to neoadjuvant chemoradiation. Huh JW, Min JJ, Lee JH, Kim HR, Kim YJ. Am J Clin Oncol; 2012 Aug 31; 35(4):340-4. PubMed ID: 21422901 [Abstract] [Full Text] [Related]
5. The Value of 18F-FDG PET/CT Imaging Combined With Pretherapeutic Ki67 for Early Prediction of Pathologic Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer. Luo J, Zhou Z, Yang Z, Chen X, Cheng J, Shao Z, Guo X, Tuan J, Fu X, Yu X. Medicine (Baltimore); 2016 Feb 31; 95(8):e2914. PubMed ID: 26937935 [Abstract] [Full Text] [Related]
7. The value of pre- and post-neoadjuvant chemotherapy F-18 FDG PET/CT scans in breast cancer: comparison with MRI. Choi EK, Yoo IR, Kim SH, Park SY, O JH, Kang BJ. Acta Radiol; 2018 Jan 31; 59(1):41-49. PubMed ID: 28427271 [Abstract] [Full Text] [Related]
8. Prediction of neoadjuvant radiation chemotherapy response and survival using pretreatment [(18)F]FDG PET/CT scans in locally advanced rectal cancer. Bang JI, Ha S, Kang SB, Lee KW, Lee HS, Kim JS, Oh HK, Lee HY, Kim SE. Eur J Nucl Med Mol Imaging; 2016 Mar 31; 43(3):422-31. PubMed ID: 26338180 [Abstract] [Full Text] [Related]
9. FDG PET/CT during neoadjuvant chemotherapy may predict response in ER-positive/HER2-negative and triple negative, but not in HER2-positive breast cancer. Koolen BB, Pengel KE, Wesseling J, Vogel WV, Vrancken Peeters MJ, Vincent AD, Gilhuijs KG, Rodenhuis S, Rutgers EJ, Valdés Olmos RA. Breast; 2013 Oct 31; 22(5):691-7. PubMed ID: 23414930 [Abstract] [Full Text] [Related]
13. Utility of MRI and PET/CT after neoadjuvant chemotherapy in breast cancer patients: correlation with pathological response grading system based on tumor cellularity. Kim T, Kang DK, An YS, Yim H, Jung YS, Kim KS, Kang SY, Kim TH. Acta Radiol; 2014 May 31; 55(4):399-408. PubMed ID: 23963151 [Abstract] [Full Text] [Related]
15. FDG-PET/CT for the early prediction of histopathological complete response to neoadjuvant chemotherapy in breast cancer patients: initial results. Buchbender C, Kuemmel S, Hoffmann O, Stahl AR, Kimmig R, Otterbach F, Ladd S, Koeninger A, Forsting M, Bockisch A, Antoch G, Heusner TA. Acta Radiol; 2012 Jul 31; 53(6):628-36. PubMed ID: 22761341 [Abstract] [Full Text] [Related]
17. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer. Birlik B, Obuz F, Elibol FD, Celik AO, Sokmen S, Terzi C, Sagol O, Sarioglu S, Gorken I, Oztop I. Magn Reson Imaging; 2015 Feb 31; 33(2):201-12. PubMed ID: 25460330 [Abstract] [Full Text] [Related]